Versant Affiliates Fund V, L.P.'s Form 4 filing
Repare Therapeutics Inc.RPTX · filed Jun 7, 2022
- Accession no.
- 0000899243-22-021348
- Filed
- Jun 7, 2022, 4:36 PM ET
- Trade date
- Jun 3-6, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 15 non-derivative transactions. Open-market sales total $9.19M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Versant Affiliates Fund V, L.P.CIK 0001589095 | 10% Owner |
| Versant Venture Capital V, L.P.CIK 0001589097 | 10% Owner |
| Versant Ophthalmic Affiliates I, L.P.CIK 0001589098 | 10% Owner |
| Versant Venture Capital V (Canada), LPCIK 0001612235 | 10% Owner |
| Versant Ventures V GP-GP (Canada), Inc.CIK 0001619297 | 10% Owner |
| Versant Ventures V, LLCCIK 0001619298 | 10% Owner |
| Versant Venture Capital VI, L.P.CIK 0001687880 | 10% Owner |
| Versant Ventures V (Canada), L.P.CIK 0001716490 | 10% Owner |
| Versant Ventures VI GP-GP, LLCCIK 0001777652 | 10% Owner |
| Versant Ventures VI GP, L.P.CIK 0001777654 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 | Common Shares | SSaleDisposed | −250,000 | $12.25F1 | −$3,062,925 | 2,344,451 | Indirect | |
| Jun 3, 2022 | Common Shares | SSaleDisposed | −438,795 | $12.25F1 | −$5,375,984.7 | 1,464,875 | Indirect | |
| Jun 3, 2022 | Common Shares | SSaleDisposed | −13,199 | $12.25F1 | −$161,710.19 | 44,065 | Indirect | |
| Jun 3, 2022 | Common Shares | SSaleDisposed | −14,611 | $12.25F1 | −$179,009.59 | 48,776 | Indirect | |
| Jun 3, 2022 | Common Shares | SSaleDisposed | −33,395 | $12.25F1 | −$409,145.52 | 111,484 | Indirect | |
| Jun 6, 2022 | Common Shares | JOtherDisposed | −614,315 | $0.00 | $0 | 850,560 | Indirect | |
| Jun 6, 2022 | Common Shares | JOtherAcquired | +132,692 | $0.00 | $0 | 132,692 | Direct | |
| Jun 6, 2022 | Common Shares | JOtherDisposed | −18,478 | $0.00 | $0 | 25,587 | Indirect | |
| Jun 6, 2022 | Common Shares | JOtherAcquired | +3,992 | $0.00 | $0 | 136,684 | Direct | |
| Jun 6, 2022 | Common Shares | JOtherDisposed | −20,454 | $0.00 | $0 | 28,322 | Indirect | |
| Jun 6, 2022 | Common Shares | JOtherAcquired | +4,419 | $0.00 | $0 | 141,103 | Direct | |
| Jun 6, 2022 | Common Shares | JOtherDisposed | −141,103 | $0.00 | $0 | 0 | Direct | |
| Jun 6, 2022 | Common Shares | JOtherDisposed | −46,753 | $0.00 | $0 | 64,731 | Indirect | |
| Jun 6, 2022 | Common Shares | JOtherAcquired | +10,099 | $0.00 | $0 | 10,099 | Indirect | |
| Jun 6, 2022 | Common Shares | JOtherDisposed | −10,099 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Referenced by the price of 5 transactions in Table I.
Remarks
1 of 2: Since there are 13 joint filers and EDGAR will not allow for entry of more than 10 joint filers, this Form 4 is being filed in conjunction with a Form 4 for Versant Vantage I, LP, Versant Vantage I GP, L.P. and Versant Vantage I GP-GP, LLC.